CA17129 – Catalysing transcriptomics research in cardiovascular disease
CardioRNA COST Action CA17129 is a collaborative pan-European network of multidisciplinary researchers, clinicians, and industrial partners aiming to accelerate the understanding of transcriptomics in cardiovascular disease (CVD) and further the translation of experimental data into usable applications to improve personalized medicine in this field.
PhD Student position available in RNA modification research at the Luxembourg Institute of HealthNovember 29, 2022
Check out this open position for a PhD student to study the role of RNA modifications in the diagnosis and pathophysiology of sudden cardiac arrest. This exciting and highly translational research project is available from January 2023, on a 3-year fixed term contract to work in the laboratory of EU-CardioRNA Chair Dr Yvan Devaux at […]
Call for abstracts for final EU-CardioRNA meeting, Nicosia, Cyprus 22-24 February 2023November 22, 2022
The final meeting of our CardioRNA COST Action will be held in Cyprus Feb 22-24, 2023 and will include a poster session for young investigators. Abstracts should be emailed before November 27th, 2022 to Tania (email@example.com ). Abstracts should have no more than 400 words, include a title, a co-author list with affiliations and with the first author as presenter. […]
5th CardioRNA Journal Club is scheduled on Monday, November 21, at 15:00 CEST / 14:00 BSTNovember 10, 2022
The 5th CardioRNA Journal Club is scheduled to be held online on Monday, November 21, at 15:00 CEST / 14:00 BST. Shiau-Haln Chen from Andrew Baker’s lab in Edinburgh will present her paper published in Cardiovascular Research in August 2022 “Single-cell RNA sequencing profiling of mouse endothelial cells in response to pulmonary arterial hypertension” (https://academic.oup.com/cardiovascres/article/118/11/2519/6370960?login=false […]